Zhou L - Search Results

1

Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.

Zhou L, Hou J, Fu W, Wang D, Yuan Z, Jiang H. Zhou L, et al. Leuk Res. 2008 Nov;32(11):1674-83. doi: 10.1016/j.leukres.2008.03.039. Epub 2008 May 15. Leuk Res. 2008. PMID: 18485479

2

Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.

Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Li Y, et al. Among authors: zhou l. Haematologica. 2007 Sep;92(9):1246-9. doi: 10.3324/haematol.11319. Epub 2007 Aug 1. Haematologica. 2007. PMID: 17666363 Free article.

3

[Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].

Zhou LL, Fu WJ, Yuan ZG, Wang DX, Hou J. Zhou LL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):84-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18315906 Chinese.

4

[About the treatment of multiple myeloma].

Hou J, Zhou LL. Hou J, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):649-50. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399166 Chinese. No abstract available.

5

[Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].

Zhou LL, Fu WJ, Yuan ZG, Wang DX, Hou J. Zhou LL, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):234-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843976 Chinese.

6

Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome.

Zhou L, Fu W, Yuan Z, Hou J. Zhou L, et al. Leuk Res. 2010 Nov;34(11):e306-7. doi: 10.1016/j.leukres.2010.06.027. Epub 2010 Jul 22. Leuk Res. 2010. PMID: 20650528 No abstract available.

7

Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma.

Dun X, Jiang H, Zou J, Shi J, Zhou L, Zhu R, Hou J. Dun X, et al. Among authors: zhou l. Mol Cancer. 2010 Sep 16;9:247. doi: 10.1186/1476-4598-9-247. Mol Cancer. 2010. PMID: 20846389 Free PMC article.

8

Clinical effects of autologous stem cell transplantation as consolidation treatment in 70 multiple myeloma patients: a case-controlled study.

Zhou LL, Yuan ZG, Fu WJ, Xi H, Zhang CY, Lan HF, Zhang X, Chen Y, Liu WY, Hou J. Zhou LL, et al. Chin Med J (Engl). 2011 Oct;124(19):2975-80. Chin Med J (Engl). 2011. PMID: 22040538

9

[The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma].

Lu J, Hou J, Zhang CY, Yuan ZG, Lan HF, Zhou F, Fan JL, Zhou LL, Du J, Jiang H, Jin LN, Zeng TM, Fu WJ. Lu J, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):309-12. doi: 10.3760/cma.j.issn.0253-2727.2013.04.013. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668202 Chinese.

10

[Busulfan, cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma].

Zhang CY, Fu WJ, Xi H, Zhou LL, Jiang H, Du J, Fan JL, Li R, Jin LN, Zeng TM, Hou J. Zhang CY, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):313-6. doi: 10.3760/cma.j.issn.0253-2727.2013.04.014. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668203 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,554 results

Search Page

Filters